Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COUMADIN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 55 adverse event reports in the FDA FAERS database where COUMADIN was used for Atrial fibrillation.

Most Reported Side Effects for COUMADIN

Side Effect Reports % Deaths Hosp.
International normalised ratio increased 56 18.1% 1 40
Anaemia 22 7.1% 2 20
Drug interaction 21 6.8% 0 19
Fall 20 6.5% 4 15
Contusion 19 6.1% 1 9
Epistaxis 18 5.8% 0 11
Gastrointestinal haemorrhage 18 5.8% 1 16
Diarrhoea 16 5.2% 1 12
Haemorrhage 16 5.2% 0 11
Dyspnoea 14 4.5% 2 8
Cerebrovascular accident 13 4.2% 3 9
Nausea 13 4.2% 1 7
Fatigue 12 3.9% 0 4
Haematuria 11 3.6% 0 7
Pulmonary embolism 11 3.6% 2 10

Other Indications for COUMADIN

Product used for unknown indication (50) Deep vein thrombosis (18) Anticoagulant therapy (10) Thrombosis (10) Cerebrovascular accident prophylaxis (8) Pulmonary embolism (8) Cerebrovascular accident (5)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

COUMADIN Full Profile All Atrial fibrillation Drugs COUMADIN Demographics COUMADIN Timeline